✦ LIBER ✦

Cisplatin/5-Fluorouracil Treatment of Recurrent Cervical Carcinoma: A Phase II Study with Long-Term Follow-up

✍ Scribed by Janne Kaern; Claes Tropé; Kolbein Sundfoer; Gunnar B. Kristensen

Book ID: 115616765
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 94 KB
Volume: 60
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1996.0059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Advanced or Recurrent Endom

Treatment of Advanced or Recurrent Endometrial Carcinoma with Combination of Etoposide, Cisplatin, and 5-Fluorouracil: A Phase II Study

✍ J-Y. Pierga; V. Dieras; D. Paraiso; T. Dorval; T. Palangie; P. Beuzeboc; M. Jouv 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Mitomycin-C/5-Fluorouracil/Leucovorin an

Mitomycin-C/5-Fluorouracil/Leucovorin and Hyperfractionated Radiation Therapy for Rectal Carcinoma: A Phase II Study with Long-Term Follow-up

✍ Chadi Nabhan; Avanthi Ragam; Brian Samuels; Daniel T. Milton; Leela Prasad; Arth 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

A phase II study of weekly cisplatin fol

A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma

✍ Peter G. Rose; M. Steven Piver; John H. Malfetano; Trudy R. Baker; Ronald E. Hem 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB 👁 2 views

Phase II Trial of Combination Intraperit

Phase II Trial of Combination Intraperitoneal Cisplatin and 5-Fluorouracil in Previously Treated Patients with Advanced Ovarian Cancer: Long-Term Follow-up

✍ Robert J. Morgan Jr.; Patricia Braly; Lucille Leong; Stephen Shibata; Kim Margol 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Maintenance immunotherapy in recurrent o

Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study

✍ Francesco Recchia; Ferdinando Di Orio; Giampiero Candeloro; Gabriele Guerriero; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 231 KB

A phase II study of chemotherapy of meta

A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin

✍ Robert P. Whitehead; Thomas R. Fleming; John S. Macdonald; Frederick R. Ahmann; 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 205 KB

The combination of 5-fluorouracil and cisplatin has shown encouraging results in single institution pilot studies in colorectal carcinoma. This phase II SWOG study was undertaken to further evaluate this treatment. Cisplatin was administered at a dose of 60 mg/M2 IV day 1, repeated every 21 days. 5-